Trevor Cook joined Bird & Bird in 1974 with a degree in chemistry from Southampton University.  He was admitted as a Solicitor in 1977, joining the Intellectual Property Department of Bird & Bird, where since 1981 he has been a partner.  He is President of the UK Group of the AIPPI (The International Association for the Protection of Industrial Property), Secretary to the British Copyright Council Standing Committee on Copyright and Technology, and a member of the Council of the Intellectual Property Institute.

In addition to numerous articles Trevor has authored the following books - Pharmaceuticals Biotechnology and the Law (Macmillan 1991, LexisNexis Butterworths 2009), The Protection of Regulatory Data in the Pharmaceutical and Other Sectors (Sweet & Maxwell 2000), A User’s Guide to Patents (Butterworths 2002, Tottel 2007) and A European Perspective as to the Extent to Which Experimental Use, and Certain Other, Defences to Patent Infringement, Apply to Differing Types of Research (Intellectual Property Institute 2006). He co-authors Practical Intellectual Property Precedents (Sweet & Maxwell 1998 to date) with Audrey Horton and co-authored The Copyright Directive (Jordans 2004) with Lorna Brazell. Having sat as an arbitrator he is currently working with Alejandro Garcia on a new book for Kluwer on intellectual property arbitration. He is one of the General Editors of The Modern Law of Patents (LexisNexis Butterworths 2005). He contributes to the Chartered Institute of Patent Agents European Patents Handbook (Sweet & Maxwell) and to Vaughan & Robertson’s Law of the European Union (Oxford University Press).  He also contributed to both editions of Information Technology and the Law (Macmillan 1986, 1990), to Database Law (Jordans 1998), and to recent editions of the Chartered Institute of Patent Agents Guide to the Patents Act 1977 (Sweet & Maxwell 1990, 1995, 2001, 2009).

Significant reported cases since the mid 90’s in which he acted for one of the parties to the litigation include, in the area of regulatory law, the references to the European Court of Justice in R v Licensing Authority, ex parte Generics (UK), R v Licensing Authority, ex parte The Wellcome Foundation and R v Licensing Authority, ex parte Glaxo Operations UK and others [1999] 2 CMLR 181, R (On the application of Novartis Pharmaceuticals UK) v The Licensing Authority & others [2004] 2 CMLR 26 and Approved Prescription Services v MCA, Lilly intervening, [2004] EUCECJ C-36/03 and, in the area of intellectual property, Merrell Dow Pharmaceuticals v HN Norton [1996] RPC 76, Harrods v Harrodian School [1996] RPC 697, Beloit Technologies v Valmet Paper Machinery [1997] RPC 489, Sepracor v Hoechst Marion Roussel [1999] FSR 746, Unilever v Procter & Gamble [1999] FSR 849, Oxford Gene Technology v Affymetrix  [2001] FSR 136, Lilly-ICOS v Pfizer [2001] FSR 16, Kirin-Amgen v Transkaryotic Therapies [2004] UKHL 46, Ranbaxy v Warner Lambert [2006] EWCA 876, Teva Pharmaceuticals v Merrell Pharmaceuticals & Others [2007] EWHC 2276 and Yeda Research and Development v Rhone-Poulenc Rorer International Holdings & another [2007] UKHL 43.